- Home
- WING vs ROIV Comparison
WING vs ROIV Comparison
Compare WING & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WING
- ROIV
- Stock Information
- Founded
- WING 1994
- ROIV 2014
- Country
- WING United States
- ROIV United Kingdom
- Employees
- WING N/A
- ROIV N/A
- Industry
- WING Restaurants
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- WING Consumer Discretionary
- ROIV Health Care
- Exchange
- WING Nasdaq
- ROIV Nasdaq
- Market Cap
- WING 9.0B
- ROIV 7.8B
- IPO Year
- WING 2015
- ROIV N/A
- Fundamental
- Price
- WING $302.01
- ROIV $11.55
- Analyst Decision
- WING Strong Buy
- ROIV Buy
- Analyst Count
- WING 20
- ROIV 3
- Target Price
- WING $357.11
- ROIV $15.25
- AVG Volume (30 Days)
- WING 599.6K
- ROIV 6.5M
- Earning Date
- WING 07-30-2025
- ROIV 08-07-2025
- Dividend Yield
- WING 0.36%
- ROIV N/A
- EPS Growth
- WING 110.47
- ROIV N/A
- EPS
- WING 5.91
- ROIV N/A
- Revenue
- WING $651,112,000.00
- ROIV $29,053,000.00
- Revenue This Year
- WING $18.60
- ROIV $3.28
- Revenue Next Year
- WING $18.10
- ROIV $156.84
- P/E Ratio
- WING $51.11
- ROIV N/A
- Revenue Growth
- WING 30.98
- ROIV N/A
- 52 Week Low
- WING $204.00
- ROIV $8.73
- 52 Week High
- WING $433.86
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- WING 32.90
- ROIV 55.27
- Support Level
- WING $298.10
- ROIV $11.31
- Resistance Level
- WING $325.10
- ROIV $11.64
- Average True Range (ATR)
- WING 10.58
- ROIV 0.29
- MACD
- WING -2.99
- ROIV 0.00
- Stochastic Oscillator
- WING 10.23
- ROIV 78.60
About WING Wingstop Inc.
Founded in 1994 in Garland, Texas, Wingstop is a restaurant operator specializing in indulgent bone-in and boneless chicken wings, chicken tenders, fries, and, recently, chicken sandwiches. The firm's footprint has grown quickly since its inception, reaching north of 2,560 global stores at the end of 2024. With a 98% franchised model, Wingstop generates the lion share of its revenue from franchise royalties and advertising fees, with the remainder derived from a small footprint of company-owned stores.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.